Genomic and Molecular Signatures of Successful Patient-Derived Xenografts for Oral Cavity Squamous Cell Carcinoma.
Saved in:
| Title: | Genomic and Molecular Signatures of Successful Patient-Derived Xenografts for Oral Cavity Squamous Cell Carcinoma. |
|---|---|
| Authors: | Yen WC; Department of Otolaryngology Head and Neck Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan., Chang IY; Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.; Department of Neurosurgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan., Chang KP; Department of Otolaryngology Head and Neck Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.; College of Medicine, Chang Gung University, Taoyuan, Taiwan., Ouyang CN; Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan., Liu CR; Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Department of Medical Biotechnology and Laboratory Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan., Tsai TL; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Department of Microbiology and Immunology, College of Medicine, Chang Gung University, Taoyuan, Taiwan., Zhang YC; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Department of Microbiology and Immunology, College of Medicine, Chang Gung University, Taoyuan, Taiwan., Wang CI; Radiation Biology Research Center, Institute for Radiological Research, Chang Gung University/Chang Gung Memorial Hospital, Linkou, Taiwan., Wang YH; Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan., Yu AL; Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.; University of California San Diego, San Diego, CA, United States., Liu H; Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Division of Colon and Rectal Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan., Wu CC; Department of Otolaryngology Head and Neck Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Department of Medical Biotechnology and Laboratory Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan., Chang YS; Department of Otolaryngology Head and Neck Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan., Yu JS; Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Liver Research Center, Chang Gung Memorial Hospital, Linkou, Taiwan., Yang CY; Department of Otolaryngology Head and Neck Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Department of Microbiology and Immunology, College of Medicine, Chang Gung University, Taoyuan, Taiwan. |
| Source: | Frontiers in oncology [Front Oncol] 2022 Apr 04; Vol. 12, pp. 792297. Date of Electronic Publication: 2022 Apr 04 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2022.792297 |
